(1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A)在口腔癌细胞中的抗增殖和凋亡作用是通过氧化应激和ERK激活介导的

IF 4.7 2区 医学 Q2 IMMUNOLOGY
Ya-Ting Chuang , Wangta Liu , Tsu-Ming Chien , Yuan-Bin Cheng , Jiiang-Huei Jeng , Ching-Yeu Chen , Jen-Yang Tang , Hsueh-Wei Chang
{"title":"(1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A)在口腔癌细胞中的抗增殖和凋亡作用是通过氧化应激和ERK激活介导的","authors":"Ya-Ting Chuang ,&nbsp;Wangta Liu ,&nbsp;Tsu-Ming Chien ,&nbsp;Yuan-Bin Cheng ,&nbsp;Jiiang-Huei Jeng ,&nbsp;Ching-Yeu Chen ,&nbsp;Jen-Yang Tang ,&nbsp;Hsueh-Wei Chang","doi":"10.1016/j.intimp.2025.114615","DOIUrl":null,"url":null,"abstract":"<div><div>The anticancer effects and mechanisms of the main component (CI-A) of methanol extracts of <em>Clavularia inflat</em> have not been reported. This study explores the anti-oral cancer effect and mechanism of (1<em>R</em>*,12<em>R</em>*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) and compared with normal cells. CI-A shows oxidative-stress-dependent preferential antiproliferation of oral cancer cells without normal cell toxicity. CI-A triggers cell cycle dysregulation, apoptosis/caspase activation, cellular/mitochondrial ROS induction, glutathione depletion, and oxidative DNA damage in oral cancer but not normal cells. After testing with three MAPK (p38, JNK, and ERK) inhibitors, only the ERK inhibitor (PD98059) protects against CI-A-induced antiproliferation in oral cancer cells. CI-A upregulates phosphorylated ERK in oral cancer cells compared to normal cells. Notably, a ROS inhibitor, <em>N</em>-acetylcysteine (NAC), attenuates all CI-A-modulated changes. Moreover, the CI-A-triggered annexin V-detected apoptosis and caspase 3/8/9 activations of oral cancer cells were downregulated by PD98059. In conclusion, CI-A induces the oxidative-stress- and ERK-dependent antiproliferative and apoptotic mechanism in oral cancer cells and shows the benefit of non-cytotoxicity to normal cells.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"155 ","pages":"Article 114615"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiproliferative and apoptotic effects of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) in oral cancer cells are mediated by oxidative stress and ERK activation\",\"authors\":\"Ya-Ting Chuang ,&nbsp;Wangta Liu ,&nbsp;Tsu-Ming Chien ,&nbsp;Yuan-Bin Cheng ,&nbsp;Jiiang-Huei Jeng ,&nbsp;Ching-Yeu Chen ,&nbsp;Jen-Yang Tang ,&nbsp;Hsueh-Wei Chang\",\"doi\":\"10.1016/j.intimp.2025.114615\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The anticancer effects and mechanisms of the main component (CI-A) of methanol extracts of <em>Clavularia inflat</em> have not been reported. This study explores the anti-oral cancer effect and mechanism of (1<em>R</em>*,12<em>R</em>*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) and compared with normal cells. CI-A shows oxidative-stress-dependent preferential antiproliferation of oral cancer cells without normal cell toxicity. CI-A triggers cell cycle dysregulation, apoptosis/caspase activation, cellular/mitochondrial ROS induction, glutathione depletion, and oxidative DNA damage in oral cancer but not normal cells. After testing with three MAPK (p38, JNK, and ERK) inhibitors, only the ERK inhibitor (PD98059) protects against CI-A-induced antiproliferation in oral cancer cells. CI-A upregulates phosphorylated ERK in oral cancer cells compared to normal cells. Notably, a ROS inhibitor, <em>N</em>-acetylcysteine (NAC), attenuates all CI-A-modulated changes. Moreover, the CI-A-triggered annexin V-detected apoptosis and caspase 3/8/9 activations of oral cancer cells were downregulated by PD98059. In conclusion, CI-A induces the oxidative-stress- and ERK-dependent antiproliferative and apoptotic mechanism in oral cancer cells and shows the benefit of non-cytotoxicity to normal cells.</div></div>\",\"PeriodicalId\":13859,\"journal\":{\"name\":\"International immunopharmacology\",\"volume\":\"155 \",\"pages\":\"Article 114615\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International immunopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1567576925006058\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576925006058","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

小茴香甲醇提取物中主要成分CI-A的抗癌作用及其机制尚未见报道。本研究探讨(1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A)的抗口腔癌作用及机制,并与正常细胞进行比较。CI-A对口腔癌细胞具有氧化应激依赖性的优先抗增殖作用,但无正常细胞毒性。CI-A在口腔癌中触发细胞周期失调、凋亡/caspase激活、细胞/线粒体ROS诱导、谷胱甘肽耗损和氧化性DNA损伤,但在正常细胞中不触发。在三种MAPK (p38, JNK和ERK)抑制剂的测试中,只有ERK抑制剂(PD98059)对ci - a诱导的口腔癌细胞的抗增殖有保护作用。与正常细胞相比,CI-A上调口腔癌细胞磷酸化的ERK。值得注意的是,ROS抑制剂n -乙酰半胱氨酸(NAC)减弱了所有ci -a调节的变化。此外,PD98059可下调ci - a触发的膜联蛋白v检测的口腔癌细胞凋亡和caspase 3/8/9的激活。综上所述,CI-A在口腔癌细胞中诱导氧化应激和erk依赖性的抗增殖和凋亡机制,并显示出对正常细胞无细胞毒性的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antiproliferative and apoptotic effects of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) in oral cancer cells are mediated by oxidative stress and ERK activation
The anticancer effects and mechanisms of the main component (CI-A) of methanol extracts of Clavularia inflat have not been reported. This study explores the anti-oral cancer effect and mechanism of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) and compared with normal cells. CI-A shows oxidative-stress-dependent preferential antiproliferation of oral cancer cells without normal cell toxicity. CI-A triggers cell cycle dysregulation, apoptosis/caspase activation, cellular/mitochondrial ROS induction, glutathione depletion, and oxidative DNA damage in oral cancer but not normal cells. After testing with three MAPK (p38, JNK, and ERK) inhibitors, only the ERK inhibitor (PD98059) protects against CI-A-induced antiproliferation in oral cancer cells. CI-A upregulates phosphorylated ERK in oral cancer cells compared to normal cells. Notably, a ROS inhibitor, N-acetylcysteine (NAC), attenuates all CI-A-modulated changes. Moreover, the CI-A-triggered annexin V-detected apoptosis and caspase 3/8/9 activations of oral cancer cells were downregulated by PD98059. In conclusion, CI-A induces the oxidative-stress- and ERK-dependent antiproliferative and apoptotic mechanism in oral cancer cells and shows the benefit of non-cytotoxicity to normal cells.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.40
自引率
3.60%
发文量
935
审稿时长
53 days
期刊介绍: International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信